UCI-1
UCI-1 is a SARS-CoV-2 main protease (Mpro) cyclic peptide inhibitor with an IC50 of 160 μM. UCI-1 shows no obvious cytotoxicity at the concentration of inhibiting Mpro. UCI-1 can be used in the study of anti-COVID-19 drugs[1].
Product Specifications
UNSPSC
12352209
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CCCCN)C(NCCC1=CC=C(CC2=O)C=C1)=O)=O)=O)[C@@H](N2)CC3=CC=CC=C3
Molecular Formula
C33H45N7O7
Molecular Weight
651.75
References & Citations
[1]Kreutzer AG, et al. A cyclic peptide inhibitor of the SARS-CoV-2 main protease. Eur J Med Chem. 2021 Oct 5;221:113530.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SNRPD3-4197R 50 µg
Recombinant Rhesus Macaque SNRPD3 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
TRV-0006414-01 10 µg
Recombinant Deoxyribonuclease I Like Protein 3 (DNASE1L3)
Sign In for Pricing
View Details TRV-0006414-02 50 µg
Recombinant Deoxyribonuclease I Like Protein 3 (DNASE1L3)
Sign In for Pricing
View Details TRV-0006414-03 100 µg
Recombinant Deoxyribonuclease I Like Protein 3 (DNASE1L3)
Sign In for Pricing
View Details TRV-0006414-04 200 µg
Recombinant Deoxyribonuclease I Like Protein 3 (DNASE1L3)
Sign In for Pricing
View Details